MyAverix Finance
F · Healthcare
STARPHARMA HLDG.SP.ADR/10 (PQ6A)
Biotechnology
STARPHARMA HLDG.SP.ADR/10 (PQ6A) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $123.71M, P/E ratio is 18.00, net margin is -22.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PQ6A
STARPHARMA HLDG.SP.ADR/10 (PQ6A) — FAQ
What is STARPHARMA HLDG.SP.ADR/10's market cap?
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a reported market cap of $123.71M (data as of 2026-03-30).
What is PQ6A's P/E ratio?
The price-to-earnings (P/E) ratio for STARPHARMA HLDG.SP.ADR/10 (PQ6A) is 18.00 (data as of 2026-03-30).
Does STARPHARMA HLDG.SP.ADR/10 pay a dividend?
Dividend yield is not available in the current snapshot for STARPHARMA HLDG.SP.ADR/10 (PQ6A). Check the MyAverix Finance app for the latest dividend data.
What sector is STARPHARMA HLDG.SP.ADR/10 in?
STARPHARMA HLDG.SP.ADR/10 (PQ6A) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PQ6A listed on?
PQ6A is listed on F.
What is STARPHARMA HLDG.SP.ADR/10's net margin?
STARPHARMA HLDG.SP.ADR/10 (PQ6A) reports a net margin of -22.2% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.